Specialized Health Products Enters Agreement with B.Braun Medical S.A.S. for International Distribution of SafeStep(R) Huber Needle Set
Monday November 19, 1:00 pm ET
BOUNTIFUL, Utah--(BUSINESS WIRE)--Specialized Health Products International, Inc. (OTCBB:SHPI - News), a leading developer and marketer of proprietary safety medical products, today announced that it has entered into an agreement with B.Braun Medical S.A.S. for the exclusive supply and distribution of SafeStep® Huber Needle Set in worldwide markets, excluding the United States and Canada. Under the terms of the agreement, Specialized Health Products will provide finished goods to B.Braun Medical for marketing under B.Braun’s private label and branded as Surecan® SafeStep®. The agreement is for an initial term of three years and includes minimum purchase requirements for the life of the agreement.
“While Specialized Health Products is the leader in the U.S. safety Huber needle market, expansion into international markets is an important and relatively untapped element of our growth strategy,” commented Jeff Soinski, President and CEO of Specialized Health Products. “By aligning ourselves with B.Braun Medical, the European market leader in vascular access ports, which Huber needles are used to access, we believe that we are well-positioned to efficiently and effectively enter Europe and other key international markets with our fast-growing SafeStep® product line.”
“Surecan® SafeStep® will help us grow our global market share in access ports, and contribute to the everyday safety of medical staff in the workplace, a pioneering area for the B.Braun group,” said Jean-Michel Actis, Vice-President/Access Port Systems and Peripheral Vascular Systems. “Our partnership with Specialized Health Products is an enhancing factor for our innovation strategy to provide solutions whenever an implanted port system can be used to access a target area in the body with relation to blood and/or treatments.”
About Specialized Health Products International, Inc.
Specialized Health Products International, Inc. is a leading developer, manufacturer and marketer of proprietary disposable medical products for clinician and patient safety. Specialized Health Products has developed multiple safety needle products based upon a broad intellectual property portfolio that applies to virtually all medical needles used today. Specialized Health Products is a market leader in safety Huber needles, with four complementary product offerings. The Company has licensed or supplies other products to leading global healthcare companies, including Covidien, Bard Access Systems, and BD Medical. For more information about Specialized Health Products, visit the Company’s website at www.shpi.com.
About B.Braun Medical S.A.S.
B.Braun Medical S.A.S. is the French subsidiary of B.Braun Melsungen A.G., one of the world’s leading companies in international healthcare, with a workforce of 33,000 and presence in more than 50 countries. With the motto “Sharing Expertise,” the B.Braun Group pledge to use, share and broaden knowledge in dialogue with the customers, in order to provide integrated system solutions. B.Braun Medical S.A.S. has both local and global responsibilities: the latter cover access port systems, endovascular systems, woundcare, stomacare and continence care. For more information, visit the websites at www.bbraun.com and www.bbraun.fr.
This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The Company may experience significant fluctuations in future operating results due to a number of economic conditions, risks in product and technology development, the effect of the Company's accounting policies and other risk factors detailed in the Company's SEC filings. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the Company and its operations, are included on certain forms the Company files with the Securities and Exchange Commission.
Contact:
Specialized Health Products International, Inc.
David Green, Chief Financial Officer, 801-298-3360
dgreen@shpi.com
or
CCG Investor Relations
Sean Collins, Senior Partner, 310-477-9800
sean.collins@ccgir.com
--------------------------------------------------------------------------------
Source: Specialized Health Products International, Inc.
